title: Effects of Resveratrol on p66Shc phosphorylation in cultured prostate cells.
abstract: There is increasing evidence that diet plays a crucial role in age-related diseases and cancer. Oxidative stress is a conceivable link between diet and diseases, thus food antioxidants, counteracting the damage caused by oxidation, are potential tools for fight age-related diseases and cancer. Resveratrol (RSV), a polyphenolic antioxidant from grapes, has gained enormous attention particularly because of its ability to induce growth arrest and apoptosis in cancer cells, and it has been proposed as both chemopreventive and therapeutic agent for cancer and other diseases. Even though the effects of RSV have been studied in prostate cancer cells and animal models, little is known about its effects on normal cells and tissues. To address this issue, we have investigated the effects of RSV on EPN cells, a human non-transformed prostate cell line, focusing on the relationship between RSV and p66Shc, a redox enzyme whose activities strikingly intersect those of RSV. p66Shc activity is regulated by phosphorylation of serine 36 (Ser36) and has been related to mitochondrial oxidative stress, apoptosis induction, regulation of cell proliferation and migration. Here we show that RSV inhibits adhesion, proliferation and migration of EPN cells, and that these effects are associated to induction of dose- and time-dependent p66Shc-Ser36 phosphorylation and ERK1/2 de-phosphorylation. Moreover, we found that RSV is able to activate also p52Shc, another member of the Shc protein family. These data show that RSV affects non-transformed prostate epithelial cells and suggest that Shc proteins may be key contributors of RSV effects on prostate cells.
authors.affiliation: Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy;
authors.forename: A
authors.initials: A
authors.lastname: Conte
authors.affiliation: Institute of Endocrinology and Experimental Oncology, CNR, Naples, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Procaccini
authors.affiliation: Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy;
authors.forename: P
authors.initials: P
authors.lastname: Iannelli
authors.affiliation: Institute of Endocrinology and Experimental Oncology, CNR, Naples, Italy.; Fondazione GENS Onlus, Naples Italy.
authors.forename: A
authors.initials: A
authors.lastname: Kisslinger
authors.affiliation: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), Italy; Centro Sanitario, University of Calabria, Arcavacata di Rende (CS), Italy;
authors.forename: F
authors.initials: F
authors.lastname: De Amicis
authors.affiliation: Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy;
authors.forename: G M
authors.initials: GM
authors.lastname: Pierantoni
authors.affiliation: Department of Sciences and Technologies, University of Sannio, Benevento, Italy;
authors.forename: F P
authors.initials: FP
authors.lastname: Mancini
authors.affiliation: Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy;; Institute of Endocrinology and Experimental Oncology, CNR, Naples, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Matarese
authors.affiliation: Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy;; Fondazione GENS Onlus, Naples Italy.
authors.forename: D
authors.initials: D
authors.lastname: Tramontano
keywords: Resveratrol; Shc; age-related diseases; prostate